stockrowHeartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
Follow HTFL
Alert me
Heartflow, Inc. (HTFL) Return on equity
Heartflow, Inc.'s return on equity over the twelve months to 30 June 2026 was 38.5%, down 3.3 percentage points from fiscal 2025 (41.8%). That is above the Health Information Services industry median of −3.15% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 41.8% | 30.02 |
| FY2024 | 11.8% | 11.78 |
| FY2023 | 0.00% | — |
Return on equity against peers
| Company | Return on equity |
|---|---|
| HNGE Hinge Health Inc. compare | 41.4% |
| HTFL Heartflow, Inc. | 38.5% |
| DOCS Doximity, Inc. compare | 13.8% |
| HQY HealthEquity, Inc. compare | 11.4% |
| PRVA Privia Health Group, Inc. compare | 4.25% |
| WAY Waystar Holding Corp. compare | 3.72% |
| OMCL Omnicell, Inc. compare | 0.00% |
| TDOC Teladoc Health, Inc. compare | −11.5% |
| SDGR Schrodinger, Inc. compare | −19.0% |
| Health Information Services industry median | −3.15% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on HTFL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement